Filing Details
- Accession Number:
- 0001140361-17-008656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 16:52:01
- Reporting Period:
- 2017-02-17
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 16:52:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1557543 | North Tide Capital, Llc | 500 Boylston Street Suite 1860 Boston MA 02116 | No | No | Yes | No | |
1594068 | Conan Laughlin | 500 Boylston Street Suite 1860 Boston MA 02116 | Yes | No | Yes | No | |
1594882 | North Tide Capital Master, Lp | 500 Boylston Street Suite 1860 Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-17 | 300 | $1.11 | 12,463,500 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2017-02-21 | 52,164 | $1.10 | 12,411,336 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2017-02-22 | 109,336 | $1.11 | 12,302,000 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- North Tide Capital, LLC ("North Tide") serves as investment manager for North Tide Capital Master, LP (the "Master Fund") and a managed account (the "Account"). Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
- Of the shares sold on February 17, 2017, 277 shares were held for the account of the Master Fund, 23 shares were held for the Account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
- Of the shares sold on February 21, 2017, 48,237 shares were held for the account of the Master Fund, 3,927 shares were held for the Account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin.
- Of the shares sold on February 22, 2017, 101,105 shares were held for the account of the Master Fund, 8,231 shares were held for the account of the Account, and all of such shares may be deemed to have been beneficially owned by North Tide and Mr. Laughlin. As of February 22, 2017, 10,752,276 shares were held for the account of the Master Fund, 1,549,724 shares were held for the account of the Account, and all of such shares may be deemed beneficially owned by North Tide and Mr. Laughlin.